Molecular mechanisms of enhanced expression of the chemokine interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial cells
Cystic fibrosis (CF) is a fatal disease caused by a mutation of the CFTR gene and severe inflammation of the lungs. The inflammatory process is characterised by increased production of the potent neutrophil-attracting chemokine interleukin 8 (CXCL8), but the mechanism responsible is poorly understoo...
| Main Author: | Poghosyan, Anna |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/27801/ |
Similar Items
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells
by: Poghosyan, Anna, et al.
Published: (2016)
by: Poghosyan, Anna, et al.
Published: (2016)
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017)
by: Rowbotham, Nicola J., et al.
Published: (2017)
Working with the patient and clinical community to deliver clinical research in cystic fibrosis. James Lind CF Phase II
by: Smith, S.J., et al.
Published: (2018)
by: Smith, S.J., et al.
Published: (2018)
Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)
by: Hurley, M.N., et al.
Published: (2011)
Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)
by: Forrester, Doug L., et al.
Published: (2015)
European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Xbox Kinectâ„¢ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)
by: Holmes, H., et al.
Published: (2013)
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)
by: Hurley, Matthew, et al.
Published: (2017)
Understanding the Costs of Care for Cystic Fibrosis: an Analysis by Age and Health State
by: Van Gool, K., et al.
Published: (2013)
by: Van Gool, K., et al.
Published: (2013)
Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)
by: Norman, Richard, et al.
Published: (2012)
Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis
by: Montgomery, S.T., et al.
Published: (2018)
by: Montgomery, S.T., et al.
Published: (2018)
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)
by: Prayle, A.P., et al.
Published: (2015)
Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)
by: Jain, Kamini
Published: (2018)
Application of a human primary epithelial-fibroblast co-culture system to study fibrosis
by: Richardson, Jaineeta
Published: (2017)
by: Richardson, Jaineeta
Published: (2017)
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)
by: Monaghan, Tanya M., et al.
Published: (2017)
Interventions for the eradication of meticillin-resistant
Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)
by: Smyth, Alan R.
Published: (2015)
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)
by: Hurley, M.N., et al.
Published: (2012)
Rate of improvement of CF life expectancy exceeds that of general population: observational death registration study
by: Hurley, Matthew, et al.
Published: (2014)
by: Hurley, Matthew, et al.
Published: (2014)
Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)
by: Palser, Sally C.
Published: (2024)
Development of a transition readiness scale for young adults with cystic fibrosis: face and content validity
by: Dudman, Lauren, et al.
Published: (2011)
by: Dudman, Lauren, et al.
Published: (2011)
Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
by: Delatycki, M., et al.
Published: (2014)
by: Delatycki, M., et al.
Published: (2014)
Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)
by: Forrester, Doug L., et al.
Published: (2013)
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
by: Elborn, J. Stuart, et al.
Published: (2015)
by: Elborn, J. Stuart, et al.
Published: (2015)
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
by: Flume, Patrick, et al.
Published: (2016)
by: Flume, Patrick, et al.
Published: (2016)
Elucidating the interaction of CF airway epithelial cells and rhinovirus: Using the host-pathogen relationship to identify future therapeutic strategies
by: Ling, K.M., et al.
Published: (2018)
by: Ling, K.M., et al.
Published: (2018)
Use of a primary epithelial cell screening tool to investigate phage therapy in cystic fibrosis
by: Trend, S., et al.
Published: (2018)
by: Trend, S., et al.
Published: (2018)
Hypoxia and sterile inflammation in cystic fibrosis airways: Mechanisms and potential therapies
by: Montgomery, S.T., et al.
Published: (2017)
by: Montgomery, S.T., et al.
Published: (2017)
The role of histone arginine methylation in cytokine/chemokine gene expression in airway smooth muscle cells in asthma
by: Kaczmarek, Klaudia
Published: (2019)
by: Kaczmarek, Klaudia
Published: (2019)
Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)
by: Spencer, Daniella Lucy
Published: (2019)
Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Scoping review of the literature about family-centred care with caregivers of children with cystic fibrosis
by: Shields, L., et al.
Published: (2013)
by: Shields, L., et al.
Published: (2013)
Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)
by: Crusz, S.A.
Published: (2009)
Study of hyperpolarised 3He MRI diffusion on asthma and cystic fibrosis, and development of hyperpolarised 129Xe MRI lung imaging
by: Hardy, Steven M.
Published: (2016)
by: Hardy, Steven M.
Published: (2016)
An evaluation of the High Frequency Digit Triplet Test as a screening tool for early detection of hearing loss in individuals with Cystic Fibrosis. Protocol v2.1.
by: Smyth, Alan R., et al.
Published: (2016)
by: Smyth, Alan R., et al.
Published: (2016)
Comparison of techniques for obtaining lower airway epithelial cells from children
by: McNamara, P.S., et al.
Published: (2008)
by: McNamara, P.S., et al.
Published: (2008)
Effects of interleukin-18 modulation on the pathogenesis of malaria infection
by: Jabbarzare, Marzieh
Published: (2013)
by: Jabbarzare, Marzieh
Published: (2013)
A systematic review to identify how the current clinical trials landscape reflects the James Lind Alliance top 10 research priorities for cystic fibrosis
by: Kalaitzis, I.S., et al.
Published: (2018)
by: Kalaitzis, I.S., et al.
Published: (2018)
Alpha-1 antitrypsin mitigates the inhibition of airway epithelial cell repair by neutrophil elastase
by: Garratt, L.W., et al.
Published: (2016)
by: Garratt, L.W., et al.
Published: (2016)
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease
by: Hussein, Norita, et al.
Published: (2018)
by: Hussein, Norita, et al.
Published: (2018)
Similar Items
-
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells
by: Poghosyan, Anna, et al.
Published: (2016) -
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017) -
Working with the patient and clinical community to deliver clinical research in cystic fibrosis. James Lind CF Phase II
by: Smith, S.J., et al.
Published: (2018) -
Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011) -
Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)